Sophia Genetics SA revenue

Sophia Genetics SA's revenue was $77.3m in fiscal 2025, up 18.6% on the year before. Since fiscal 2019 ($25.4m) it has grown at a compound 20.4% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sophia Genetics SA: revenue history, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	25	28	40	48	62	65	77
Growth on the year before	—	+12.0%	+42.4%	+17.6%	+31.1%	+4.5%	+18.6%
Gross profit	18	18	25	31	43	44	52
Gross margin	70.3%	62.3%	62.4%	65.7%	68.8%	67.4%	67.4%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Sophia Genetics SA	$77.3m	18.6%	—
Optimizerx Corp	$98.7m	-5.8%	17.0%
Carecloud, Inc.	$129m	15.1%	0.8%
American Well Corp	$219m	-19.0%	-7.4%
Healthcare Triangle, Inc.	$25.7m	116.4%	-14.9%
Definitive Healthcare Corp.	$233m	-5.0%	-0.8%

Compare with peers

Head to head: OPRX vs SOPH CCLD vs SOPH AMWL vs SOPH HCTI vs SOPH

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Sophia Genetics SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sophia Genetics SA.